Evidence map›Paper›PMID 42655073›Full record

ArticleMicroorganisms2026

Multi-Locus Integration of Antimicrobial Peptide Api137 in

Ruiqian Wang, Jia Song, Bo Sun, Meiling Zhang, Kuanbo Liu, Xue Yan, Ruimin Li, Wanzhong Zhang, Chen Zhao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruiqian WangCollege of Chemical Engineering, Shenyang University of Chemical Technology, Shenyang 110142, China.ORCID 0009-0004-7415-2303
Jia SongKey Laboratory of Grain and Oil Biotechnology, Academy of National Food and Strategic Reserves Administration, Beijing 100037, China.
Bo SunKey Laboratory of Grain and Oil Biotechnology, Academy of National Food and Strategic Reserves Administration, Beijing 100037, China.
Meiling ZhangCollege of Chemical Engineering, Shenyang University of Chemical Technology, Shenyang 110142, China.
Kuanbo LiuKey Laboratory of Grain and Oil Biotechnology, Academy of National Food and Strategic Reserves Administration, Beijing 100037, China.
Xue YanKey Laboratory of Feed and Livestock and Poultry Products Quality & Safety Control, Ministry of Agriculture and Rural Affairs, New Hope Liuhe Co., Ltd., Chengdu 610023, China.
Ruimin LiKey Laboratory of Grain and Oil Biotechnology, Academy of National Food and Strategic Reserves Administration, Beijing 100037, China.
Wanzhong ZhangCollege of Chemical Engineering, Shenyang University of Chemical Technology, Shenyang 110142, China.
Chen ZhaoKey Laboratory of Grain and Oil Biotechnology, Academy of National Food and Strategic Reserves Administration, Beijing 100037, China.

Funding

Fundamental Research Funds of Non-Profit Central Institutions ZX2453
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are promising alternatives to antibiotics for combating multidrug-resistant bacteria, yet their practical application is hindered by the low content of natural AMPs and the high cost of chemical synthesis. In this study, we developed a high-efficiency heterologous expression system for the proline-rich cationic antimicrobial peptide Api137 in

Indexed as

activity detectionantimicrobial peptideheterologous expressionSaccharomyces cerevisiae CENPK2Ty transposon

Identifiers

PMID42655073
PMCPMC13515414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.